Findings from MINT will be presented at the American Academy of Neurology Annual Meeting on April 8, 2025, in San Diego.

Myasthenia gravis is a neuromuscular junction disorder with a hallmark of progressive muscle weakness and frequent ...

More patients with myasthenia gravis had mild-grade CCI vs controls (23.8% vs 15.9%; P = .0011), similar amounts from each group had moderate-grade CCI (1.7% vs 1.3%, respectively), and no ...